Breaking News

'Phenomenal' HPV vaccine data for cancer prevention

April 29, 2025
A vial of the HPV vaccine Gardasil.
Charles Rex Arbogast/APgreat

U.S. government researchers present 'phenomenal' new data on HPV vaccines

National Cancer Institute trial shows that for vaccines against human papilloma virus, a single dose prevents infection just as well as two doses.

By Matthew Herper


STAT+ | Merck KGaA to purchase SpringWorks Therapeutics in deal worth more than $3 billion

The deal for SpringWorks, which focuses on rare tumors and has two approved drugs, has an equity value of nearly $4 billion.

By Andrew Joseph


STAT+ | 'Fight for your science': Researchers urged to speak out at AACR

Senior researchers and former government officials expressed big concerns about scientific research after upheaval seen under the Trump administration. 

By Angus Chen and Matthew Herper



Chicago, ready to receive the cancer community.
Adam Feuerstein/STAT

STAT+ | Taking science's temperature at the annual AACR meeting

The American Association for Cancer Research is holding one of the first big medical meetings since the Trump administration began cuts to science.

By Angus Chen and Matthew Herper


STAT+ | Akeso wins Chinese approval for cancer drug positioned to rival Merck's Keytruda

New data show early hints of the medicine improving patient survival — the gold standard outcome of any cancer study

By Jonathan Wosen


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Cancer Briefing? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2025, All Rights Reserved.

No comments